Behind the Scenes of Amgen's Latest Options Trends
Portfolio Pulse from Benzinga Insights
Financial analysis reveals a bearish trend in Amgen's (NASDAQ:AMGN) options trading, with 53% of traders showing bearish tendencies. Significant trades indicate a targeted price range of $290.0 to $305.0. Amgen, a biotech leader, has a diverse portfolio including drugs for cancer, inflammatory diseases, and rare diseases. The stock is currently down -0.38% at $290.01, with analysts giving mixed ratings but an average target price of $338.6. Options trading suggests cautious investor sentiment despite Amgen's strong market standing and analyst support.
February 12, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Amgen's options trading shows a bearish sentiment, but analyst ratings and the company's strong product portfolio suggest potential for recovery. The stock's slight current dip contrasts with a higher average analyst target price.
The bearish options sentiment is balanced by strong analyst ratings and Amgen's solid market position. The mixed signals from options trading and analyst optimism create a neutral short-term outlook, suggesting that while there may be volatility, the company's fundamentals and market position could support recovery.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100